Cocoa contains more phenolic antioxidants than most foods. Flavonoids, including catechin, epicatechin, and procyanidins predominate in antioxidant activity. The tricyclic structure of the flavonoids determines antioxidant effects that scavenge reactive oxygen species, chelate Fe2+ and Cu+, inhibit enzymes, and upregulate antioxidant defenses. The epicatechin content of cocoa is primarily responsible for its favorable impact on vascular endothelium via its effect on both acute and chronic upregulation of nitric oxide production. Other cardiovascular effects are mediated through anti-inflammatory effects of cocoa polyphenols, and modulated through the activity of NF-κB. Antioxidant effects of cocoa may directly influence insulin resistance and, in turn, reduce risk for diabetes. Further, cocoa consumption may stimulate changes in redox-sensitive signaling pathways involved in gene expression and the immune response. Cocoa can protect nerves from injury and inflammation, protect the skin from oxidative damage from UV radiation in topical preparations, and have beneficial effects on satiety, cognitive function, and mood. As cocoa is predominantly consumed as energy-dense chocolate, potential detrimental effects of overconsumption exist, including increased risk of weight gain. Overall, research to date suggests that the benefits of moderate cocoa or dark chocolate consumption likely outweigh the risks. Antioxid. Redox Signal. 15, 2779–2811.
Actis-GorettaL, OttavianiJI, FragaCG. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem, 54:229–234. 2006.
3.
Actis-GorettaL, OttavianiJI, KeenCL, FragaCG. Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett, 555:597–600. 2003.
4.
Al-DelaimyWK, RimmEB, WillettWC, StampferMJ, HuFB. Magnesium intake and risk of coronary heart disease among men. J Am Coll Nutr, 23:63–70. 2004.
5.
AllanSM, RothwellNJ. Inflammation in central nervous system injury. Philos Trans R Soc Lond B Biol Sci, 358:1669–1677. 2003.
6.
AlmoosawiS, FyfeL, HoC, Al-DujailiE. The effect of polyphenol-rich dark chocolate on fasting capillary whole blood glucose, total cholesterol, blood pressure and glucocorticoids in healthy overweight and obese subjects. Br J Nutr, 103:842–850. 2010.
7.
AndersonTJ, UehataA, GerhardMD, MeredithIT, KnabS, DelagrangeD, LiebermanEH, GanzP, CreagerMA, YeungACet al.Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol, 26:1235–1241. 1995.
8.
AndoK, MatsuiH, FujitaM, FujitaT. Protective effect of dietary potassium against cardiovascular damage in salt-sensitive hypertension: possible role of its antioxidant action. Curr Vasc Pharmacol, 8:59–63. 2010.
9.
AndrewsRK, BerndtMC. Platelet physiology and thrombosis. Thromb Res, 114:447–453. 2004.
10.
AppelLJ, SacksFM, CareyVJ, ObarzanekE, SwainJF, MillerER3rd, ConlinPR, ErlingerTP, RosnerBA, LaranjoNM, CharlestonJ, McCarronP, BishopLM. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA, 294:2455–2464. 2005.
11.
ArlorioM, BottiniC, TravagliaF, LocatelliM, BordigaM, CoissonJD, MartelliA, TessitoreL. Protective activity of Theobroma cacao L. phenolic extract on AML12 and MLP29 liver cells by preventing apoptosis and inducing autophagy. J Agric Food Chem, 57:10612–10618. 2009.
12.
ArnalJF, Dinh-XuanAT, PueyoM, DarbladeB, RamiJ. Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci, 55:1078–1087. 1999.
13.
ArtsIC, van de PutteB, HollmanPC. Catechin contents of foods commonly consumed in The Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. J Agric Food Chem, 48:1746–1751. 2000.
14.
BabaS, NatsumeM, YasudaA, NakamuraY, TamuraT, OsakabeN, KanegaeM, KondoK. Plasma LDL and HDL cholesterol and oxidized LDL concentrations are altered in normo- and hypercholesterolemic humans after intake of different levels of cocoa powder. J Nutr, 137:1436–1441. 2007.
15.
BabaS, OsakabeN, KatoY, NatsumeM, YasudaA, KidoT, FukudaK, MutoY, KondoK. Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans. Am J Clin Nutr, 85:709–717. 2007.
16.
BabaS, OsakabeN, NatsumeM, TeraoJ. Absorption and urinary excretion of procyanidin B2 [epicatechin-(4beta-8)-epicatechin] in rats. Free Radic Biol Med, 33:142–148. 2002.
17.
BalzerJ, RassafT, HeissC, KleinbongardP, LauerT, MerxM, HeussenN, GrossHB, KeenCL, SchroeterH, KelmM. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J Am Coll Cardiol, 51:2141–2149. 2008.
18.
Barry Callebaut USA, Inc.2007. Barry Callebaut survey finds Americans love milk chocolate but are experimenting with other varieties. www.barry-callebaut.com/56?release=3400. 2010 May 12.
19.
BazzanoLA. Effects of soluble dietary fiber on low-density lipoprotein cholesterol and coronary heart disease risk. Curr Atheroscler Rep, 10:473–477. 2008.
20.
Belscak-CvitanovicA, BenkovicM, KomesD, BaumanI, HorzicD, DujmicF, MatijasecM. Physical properties and bioactive constituents of powdered mixtures and drinks prepared with cocoa and various sweeteners. J Agric Food Chem, 58:7187–7195. 2010.
21.
BerryNM, DavisonK, CoatesAM, BuckleyJD, HowePR. Impact of cocoa flavanol consumption on blood pressure responsiveness to exercise. Br J Nutr, 103:1–5. 2010.
22.
BoelsmaE, van de VijverLP, GoldbohmRA, Klopping-KetelaarsIA, HendriksHF, RozaL. Human skin condition and its associations with nutrient concentrations in serum and diet. Am J Clin Nutr, 77:348–355. 2003.
23.
BordeauxB, YanekLR, MoyTF, WhiteLW, BeckerLC, FaradayN, BeckerDM. Casual chocolate consumption and inhibition of platelet function. Prev Cardiol, 10:175–180. 2007.
24.
BourtchuladzeR, FrenguelliB, BlendyJ, CioffiD, SchutzG, SilvaAJ. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell, 79:59–68. 1994.
25.
BoweWP, JoshiSS, ShalitaAR. Diet and acne. J Am Acad Dermatol, 63:124–141. 2010.
26.
BraccoU. Effect of triglyceride structure on fat absorption. Am J Clin Nutr, 60:1002S–1009S. 1994.
27.
BruinsmaK, TarenDL. Chocolate: food or drug?J Am Diet Assoc, 99:1249–1256. 1999.
28.
BrummerP. Coronary mortality and living standard. II. Coffee, tea, cocoa, alcohol and tobacco. Acta Med Scand, 186:61–63. 1969.
29.
BuijsseB, FeskensEJ, KokFJ, KromhoutD. Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen elderly study. Arch Intern Med, 166:411–417. 2006.
30.
BuijsseB, WeikertC, DroganD, BergmannM, BoeingH. Chocolate consumption in relation to blood pressure and risk of cardiovascular disease in German adults. Eur Heart J, 31:1616–1623. 2010.
BuykenAE, FloodV, RochtchinaE, NestelP, Brand-MillerJ, MitchellP. Modifications in dietary fat quality are associated with changes in serum lipids of older adults independently of lipid medication. J Nutr, 140:88–94. 2010.
33.
CAOBISCO. Ranking of Consumption (Chocolate Confectionery)www.caobisco.com/doc_uploads/Charts/ranking_of_consumption_chocolate_confectionery_2007.pdf. 2010 Jan 5.
34.
CelermajerDS, SorensenKE, BullC, RobinsonJ, DeanfieldJE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol, 24:1468–1474. 1994.
35.
CerielloA, MotzE. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol, 24:816–823. 2004.
36.
ChakrabortiS, ChakrabortiT, MandalM, MandalA, DasS, GhoshS. Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem, 238:163–179. 2002.
37.
ChakravarthyBK, GuptaS, GodeKD. Functional beta cell regeneration in the islets of pancreas in alloxan induced diabetic rats by (-)-epicatechin. Life Sci, 31:2693–2697. 1982.
38.
ChenD, DanielKG, KuhnDJ, KaziA, BhuiyanM, LiL, WangZ, WanSB, LamWH, ChanTH, DouQP. Green tea and tea polyphenols in cancer prevention. Front Biosci, 9:2618–2631. 2004.
39.
Chevaux KAJL, VillarMEet al.Proximate, mineral and procyanidin content of certain foods and beverages consumed by the Kuna Amerinds of Panama. J Food Comp Anal, 14:553–563. 2001.
40.
CooperKA, Campos-GimenezE, Jimenez AlvarezD, NagyK, DonovanJL, WilliamsonG. Rapid reversed phase ultra-performance liquid chromatography analysis of the major cocoa polyphenols and inter-relationships of their concentrations in chocolate. J Agric Food Chem, 55:2841–2847. 2007.
41.
CooperKA, DonovanJL, WaterhouseAL, WilliamsonG. Cocoa and health: a decade of research. Br J Nutr, 99:1–11. 2008.
CortiR, HutterR, BadimonJJ, FusterV. Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis. J Thromb Thrombolysis, 17:35–44. 2004.
44.
CotelleN. Role of flavonoids in oxidative stress. Curr Top Med Chem, 1:569–590. 2001.
45.
CrewsWDJr., HarrisonDW, WrightJW. A double-blind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults. Am J Clin Nutr, 87:872–880. 2008.
46.
D'ArchivioM, FilesiC, VariR, ScazzocchioB, MasellaR. Bioavailability of the polyphenols: status and controversies. Int J Mol Sci, 11:1321–1342. 2010.
47.
DavidoviciBB, WolfR. The role of diet in acne: facts and controversies. Clin Dermatol, 28:12–16. 2010.
48.
DavisonK, BerryNM, MisanG, CoatesAM, BuckleyJD, HowePR. Dose-related effects of flavanol-rich cocoa on blood pressure. J Hum Hypertens, 24:568–576. 2010.
49.
DavisonK, CoatesAM, BuckleyJD, HowePR. Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int J Obes (Lond), 32:1289–1296. 2008.
50.
De BenoistB, McleanE, EgliI, CogswellM. Worldwide Prevalence of Anaemia 1993–2005. Geneva: World Health Organization, 2008.
51.
De CaterinaR, ZampolliA, Del TurcoS, MadonnaR, MassaroM. Nutritional mechanisms that influence cardiovascular disease. Am J Clin Nutr, 83:421S–426S. 2006.
52.
DeanfieldJE, HalcoxJP, RabelinkTJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation, 115:1285–1295. 2007.
DeprezS, MilaI, HuneauJF, TomeD, ScalbertA. Transport of proanthocyanidin dimer, trimer, and polymer across monolayers of human intestinal epithelial Caco-2 cells. Antioxid Redox Signal, 3:957–967. 2001.
55.
DeschS, KoblerD, SchmidtJ, SonnabendM, AdamsV, SarebanM, EitelI, BluherM, SchulerG, ThieleH. Low vs. higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients. Am J Hypertens, 23:694–700. 2010.
56.
DeschS, SchmidtJ, KoblerD, SonnabendM, EitelI, SarebanM, RahimiK, SchulerG, ThieleH. Effect of cocoa products on blood pressure: systematic review and meta-analysis. Am J Hypertens, 23:97–103. 2010.
57.
DesjardinsF, BalligandJL. Nitric oxide-dependent endothelial function and cardiovascular disease. Acta Clin Belg, 61:326–334. 2006.
58.
DeVaultKR, CastellDO, American College ofG. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol, 100:190–200. 2005.
59.
di GiuseppeR, Di CastelnuovoA, CentrittoF, ZitoF, De CurtisA, CostanzoS, VohnoutB, SieriS, KroghV, DonatiMB, de GaetanoG, IacovielloL. Regular consumption of dark chocolate is associated with low serum concentrations of C-reactive protein in a healthy Italian population. J Nutr, 138:1939–1945. 2008.
60.
DillingerTL, BarrigaP, EscarcegaS, JimenezM, Salazar LoweD, GrivettiLE. Food of the gods: cure for humanity? A cultural history of the medicinal and ritual use of chocolate. J Nutr, 130:2057S–7072S. 2000.
61.
DjousseL, HopkinsPN, ArnettDK, PankowJS, BoreckiI, NorthKE, Curtis EllisonR. Chocolate consumption is inversely associated with calcified atherosclerotic plaque in the coronary arteries: The NHLBI Family Heart Study. Clin Nutr, 30:38–43. 2011.
62.
DonovanJL, ManachC, RiosL, MorandC, ScalbertA, RemesyC. Procyanidins are not bioavailable in rats fed a single meal containing a grapeseed extract or the procyanidin dimer B3. Br J Nutr, 87:299–306. 2002.
63.
EharaS, UedaM, NarukoT, HazeK, ItohA, OtsukaM, KomatsuR, MatsuoT, ItabeH, TakanoT, TsukamotoY, YoshiyamaM, TakeuchiK, YoshikawaJ, BeckerAE. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation, 103:1955–1960. 2001.
64.
EnglerMB, EnglerMM. The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease. Nutr Rev, 64:109–118. 2006.
65.
EnglerMB, EnglerMM, ChenCY, MalloyMJ, BrowneA, ChiuEY, KwakHK, MilburyP, PaulSM, BlumbergJ, Mietus-SnyderML. Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr, 23:197–204. 2004.
66.
FaridiZ, NjikeVY, DuttaS, AliA, KatzDL. Acute dark chocolate and cocoa ingestion and endothelial function: a randomized controlled crossover trial. Am J Clin Nutr, 88:58–63. 2008.
67.
FarouqueHM, LeungM, HopeSA, BaldiM, SchechterC, CameronJD, MeredithIT. Acute and chronic effects of flavanol-rich cocoa on vascular function in subjects with coronary artery disease: a randomized double-blind placebo-controlled study. Clin Sci (Lond), 111:71–80. 2006.
68.
FathiR, HaluskaB, IsbelN, ShortL, MarwickTH. The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol, 43:616–623. 2004.
69.
FedericoA, MorgilloF, TuccilloC, CiardielloF, LoguercioC. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer, 121:2381–2386. 2007.
70.
FerdowsianHR, LevinS. Does diet really affect acne?Skin Therapy Lett, 15:1–2, 5. 2010.
71.
FernandezML. Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Curr Opin Lipidol, 12:35–40. 2001.
72.
FisherND, HollenbergNK. Aging and vascular responses to flavanol-rich cocoa. J Hypertens, 24:1575–1580. 2006.
Food and Agriculture Organization of the United Nations. Medium-Term Prospects for Agricultural Commodities: Projections to the Year 2010. 2003. www.fao.org/docrep/006/y5143e/y5143e0x.htm#bm33. 2010 May 10.
77.
FordES, BergmannMM, KrogerJ, SchienkiewitzA, WeikertC, BoeingH. Healthy living is the best revenge: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam study. Arch Intern Med, 169:1355–1362. 2009.
78.
FrancisST, HeadK, MorrisPG, MacdonaldIA. The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. J Cardiovasc Pharmacol, 47,Suppl 2:S215–S220. 2006.
79.
FrancoOH, BonneuxL, de LaetC, PeetersA, SteyerbergEW, MackenbachJP. The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%BMJ, 329:1447–1450. 2004.
80.
FriedmanM, LevinCE, LeeSU, KozukueN. Stability of green tea catechins in commercial tea leaves during storage for 6 months. J Food Sci, 74:H47–H51. 2009.
81.
GewaltigMT, KojdaG. Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res, 55:250–260. 2002.
GibbCM, DaviesPT, GloverV, SteinerTJ, Clifford RoseF, SandlerM. Chocolate is a migraine-provoking agent. Cephalalgia, 11:93–95. 1991.
84.
GrassiD, DesideriG, FerriC. Blood pressure and cardiovascular risk: what about cocoa and chocolate?Arch Biochem Biophys, 501:112–115. 2010.
85.
GrassiD, DesideriG, NecozioneS, LippiC, CasaleR, ProperziG, BlumbergJB, FerriC. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr, 138:1671–1676. 2008.
86.
GrassiD, NecozioneS, LippiC, CroceG, ValeriL, PasqualettiP, DesideriG, BlumbergJB, FerriC. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension, 46:398–405. 2005.
87.
GuL, HouseSE, WuX, OuB, PriorRL. Procyanidin and catechin contents and antioxidant capacity of cocoa and chocolate products. J Agric Food Chem, 54:4057–4061. 2006.
88.
GumsJG. Magnesium in cardiovascular and other disorders. Am J Health Syst Pharm, 61:1569–1576. 2004.
89.
GurbelPA, SerebruanyVL. Adhesion molecules, platelet activation, and cardiovascular risk. Am Heart J, 143:196–198. 2002.
90.
HamedMS, GambertS, BlidenKP, BailonO, SinglaA, AntoninoMJ, HamedF, TantryUS, GurbelPA. Dark chocolate effect on platelet activity, C-reactive protein and lipid profile: a pilot study. South Med J, 101:1203–1208. 2008.
91.
HanhinevaK, TorronenR, Bondia-PonsI, PekkinenJ, KolehmainenM, MykkanenH, PoutanenK. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci, 11:1365–1402. 2010.
92.
HeinrichU, NeukamK, TronnierH, SiesH, StahlW. Long-term ingestion of high flavanol cocoa provides photoprotection against UV-induced erythema and improves skin condition in women. J Nutr, 136:1565–1569. 2006.
93.
HeissC, DejamA, KleinbongardP, ScheweT, SiesH, KelmM. Vascular effects of cocoa rich in flavan-3-ols. JAMA, 290:1030–1031. 2003.
94.
HeissC, FinisD, KleinbongardP, HoffmannA, RassafT, KelmM, SiesH. Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week. J Cardiovasc Pharmacol, 49:74–80. 2007.
95.
HeissC, JahnS, TaylorM, RealWM, AngeliFS, WongML, AmabileN, PrasadM, RassafT, OttavianiJI, MihardjaS, KeenCL, SpringerML, BoyleA, GrossmanW, GlantzSA, SchroeterH, YeghiazariansY. Improvement of endothelial function with dietary flavanols is associated with mobilization of circulating angiogenic cells in patients with coronary artery disease. J Am Coll Cardiol, 56:218–224. 2010.
96.
HeissC, KleinbongardP, DejamA, PerreS, SchroeterH, SiesH, KelmM. Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol, 46:1276–1283. 2005.
97.
HeptinstallS, MayJ, FoxS, Kwik-UribeC, ZhaoL. Cocoa flavanols and platelet and leukocyte function: recent in vitro and ex vivo studies in healthy adults. J Cardiovasc Pharmacol, 47,Suppl 2:S197–S205; discussion S206–S2092006.
98.
HermannF, SpiekerLE, RuschitzkaF, SudanoI, HermannM, BinggeliC, LuscherTF, RiesenW, NollG, CortiR. Dark chocolate improves endothelial and platelet function. Heart, 92:119–120. 2006.
99.
HertogMG, KromhoutD, AravanisC, BlackburnH, BuzinaR, FidanzaF, GiampaoliS, JansenA, MenottiA, NedeljkovicSet al.Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med, 155:381–386. 1995.
100.
HettsSW. To die or not to die: an overview of apoptosis and its role in disease. JAMA, 279:300–307. 1998.
101.
HiiCS, HowellSL. Effects of flavonoids on insulin secretion and 45Ca2+ handling in rat islets of Langerhans. J Endocrinol, 107:1–8. 1985.
102.
HillAJ, Heaton-BrownL. The experience of food craving: a prospective investigation in healthy women. J Psychosom Res, 38:801–814. 1994.
103.
HollenbergN. Vascular action of cocoa flavanols in humans: the roots of the story. J Cardiovasc Pharmacol, 47,Suppl 2:S99–S102discussion S119–S1212006.
104.
HollenbergNK, FisherND, McCulloughML. Flavanols, the Kuna, cocoa consumption, and nitric oxide. J Am Soc Hypertens, 3:105–112. 2009.
105.
HollenbergNK, MartinezG, McCulloughM, MeinkingT, PassanD, PrestonM, RiveraA, TaplinD, Vicaria-ClementM. Aging, acculturation, salt intake, and hypertension in the Kuna of Panama. Hypertension, 29:171–176. 1997.
HoltRR, LazarusSA, SullardsMC, ZhuQY, SchrammDD, HammerstoneJF, FragaCG, SchmitzHH, KeenCL. Procyanidin dimer B2 [epicatechin-(4beta-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am J Clin Nutr, 76:798–804. 2002.
108.
HooperL, KroonPA, RimmEB, CohnJS, HarveyI, Le CornuKA, RyderJJ, HallWL, CassidyA. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr, 88:38–50. 2008.
109.
HormesJM, RozinP. Perimenstrual chocolate craving. What happens after menopause?Appetite, 53:256–259. 2009.
110.
HuFB, MalikVS. Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence. Physiol Behav, 100:47–54. 2010.
111.
HuangH, MaiW, LiuD, HaoY, TaoJ, DongY. The oxidation ratio of LDL: a predictor for coronary artery disease. Dis Markers, 24:341–349. 2008.
112.
HunotS, HirschEC. Neuroinflammatory processes in Parkinson's disease. Ann Neurol, 53,Suppl 3:S49–S58; discussion S58–S602003.
113.
HunterJE, ZhangJ, Kris-EthertonPM. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr, 91:46–63. 2010.
114.
HurstWJ, PayneMJ, MillerKB, StuartDA. Stability of cocoa antioxidants and flavan-3-ols over time. J Agric Food Chem, 57:9547–9550. 2009.
115.
International Cocoa Organization. Annual Forecasts of Production and Consumption and Estimates of Production Levels to Achieve Equilibrium in the World Cocoa Market. 2008. www.icco.org/Attachment.aspx?Id=fgn64825. 2010 May 10.
116.
IshikawaA, YamashitaH, HiemoriM, InagakiE, KimotoM, OkamotoM, TsujiH, MemonAN, MohammadioA, NatoriY. Characterization of inhibitors of postprandial hyperglycemia from the leaves of Nerium indicum. J Nutr Sci Vitaminol (Tokyo), 53:166–173. 2007.
117.
JalilAM, IsmailA, PeiCP, HamidM, KamaruddinSH. Effects of cocoa extract on glucometabolism, oxidative stress, and antioxidant enzymes in obese-diabetic (Ob-db) rats. J Agric Food Chem, 56:7877–7884. 2008.
118.
JanszkyI, MukamalKJ, LjungR, AhnveS, AhlbomA, HallqvistJ. Chocolate consumption and mortality following a first acute myocardial infarction: the Stockholm Heart Epidemiology Program. J Intern Med, 266:248–257. 2009.
119.
JenkinsDJ, KendallCW, VuksanV, VidgenE, WongE, AugustinLS, FulgoniV3rd. Effect of cocoa bran on low-density lipoprotein oxidation and fecal bulking. Arch Intern Med, 160:2374–2379. 2000.
120.
JeongSY, SeolDW. The role of mitochondria in apoptosis. BMB Rep, 41:11–22. 2008.
121.
JiaL, LiuX, BaiYY, LiSH, SunK, HeC, HuiR. Short-term effect of cocoa product consuption on lipid profile: a meta-analysis of randomized controlled trials. Am J Clin Nutr, 92:218–225. 2010.
122.
JobgenWS, FriedSK, FuWJ, MeiningerCJ, WuG. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem, 17:571–588. 2006.
123.
JohnstonK, SharpP, CliffordM, MorganL. Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Lett, 579:1653–1657. 2005.
124.
JosephJA, Shukitt-HaleB, DenisovaNA, BielinskiD, MartinA, McEwenJJ, BickfordPC. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci, 19:8114–8121. 1999.
125.
KaltenbachT, CrockettS, GersonLB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med, 166:965–971. 2006.
126.
KatanMB, ZockPL, MensinkRP. Effects of fats and fatty acids on blood lipids in humans: an overview. Am J Clin Nutr, 60:1017S–1022S. 1994.
127.
KatzDL. Life and death, knowledge and power: why knowing what matters is not what's the matter. Arch Intern Med, 169:1362–1363. 2009.
128.
KennyTP, KeenCL, SchmitzHH, GershwinME. Immune effects of cocoa procyanidin oligomers on peripheral blood mononuclear cells. Exp Biol Med (Maywood), 232:293–300. 2007.
129.
KennyTP, ShuSA, MoritokiY, KeenCL, GershwinME. Cocoa flavanols and procyanidins can modulate the lipopolysaccharide activation of polymorphonuclear cells in vitro. J Med Food, 12:1–7. 2009.
130.
KeoghJB, GriegerJA, NoakesM, CliftonPM. Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler Thromb Vasc Biol, 25:1274–1279. 2005.
131.
KeoghJB, McInerneyJ, CliftonPM. The effect of milk protein on the bioavailability of cocoa polyphenols. J Food Sci, 72:S230–S233. 2007.
132.
KhanN, AfaqF, MukhtarH. Apoptosis by dietary factors: the suicide solution for delaying cancer growth. Carcinogenesis, 28:233–239. 2007.
133.
KimJA, MontagnaniM, KohKK, QuonMJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation, 113:1888–1904. 2006.
134.
KimJE, SonJE, JungSK, KangNJ, LeeCY, LeeKW, LeeHJ. Cocoa polyphenols suppress TNF-alpha-induced vascular endothelial growth factor expression by inhibiting phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase kinase-1 (MEK1) activities in mouse epidermal cells. Br J Nutr, 104:957–964. 2010.
135.
KimYS, JohTH. Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease. Exp Mol Med, 38:333–347. 2006.
136.
KlevayLM. Cardiovascular disease from copper deficiency—a history. J Nutr, 130:489S–492S. 2000.
137.
Kris-EthertonPM, DerrJA, MustadVA, SeligsonFH, PearsonTA. Effects of a milk chocolate bar per day substituted for a high-carbohydrate snack in young men on an NCEP/AHA Step 1 Diet. Am J Clin Nutr, 60:1037S–1042S. 1994.
138.
Kris-EthertonPM, KeenCL. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol, 13:41–49. 2002.
LavoieJL, SigmundCD. Minireview: overview of the renin-angiotensin system—an endocrine and paracrine system. Endocrinology, 144:2179–2183. 2003.
141.
LecumberriE, MateosR, RamosS, AliaM, RuperezP, GoyaL, Izquierdo-PulidoM, BravoL. Characterization of cocoa fiber and its effect on the antioxidant capacity of serum in rats]Nutr Hosp, 21:622–628. 2006.
142.
LeeIK, KimHS, BaeJH. Endothelial dysfunction: its relationship with acute hyperglycaemia and hyperlipidemia. Int J Clin Pract Suppl, 129:59–64. 2002.
143.
LeeKW, KunduJK, KimSO, ChunKS, LeeHJ, SurhYJ. Cocoa polyphenols inhibit phorbol ester-induced superoxide anion formation in cultured HL-60 cells and expression of cyclooxygenase-2 and activation of NF-kappaB and MAPKs in mouse skin in vivo. J Nutr, 136:1150–1155. 2006.
144.
LeoneN, CourbonD, DucimetiereP, ZureikM. Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality. Epidemiology, 17:308–314. 2006.
145.
LiH, ForstermannU. Prevention of atherosclerosis by interference with the vascular nitric oxide system. Curr Pharm Des, 15:3133–3145. 2009.
146.
LokeWM, HodgsonJM, ProudfootJM, McKinleyAJ, PuddeyIB, CroftKD. Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr, 88:1018–1025. 2008.
147.
LuscherTF, BartonM. Biology of the endothelium. Clin Cardiol, 20:II-3–II-10. 1997.
148.
MachtM, DettmerD. Everyday mood and emotions after eating a chocolate bar or an apple. Appetite, 46:332–336. 2006.
149.
MachtM, MuellerJ. Immediate effects of chocolate on experimentally induced mood states. Appetite, 49:667–674. 2007.
150.
MachtM, MuellerJ. Interactive effects of emotional and restrained eating on responses to chocolate and affect. J Nerv Ment Dis, 195:1024–1026. 2007.
151.
MackenzieGG, CarrasquedoF, DelfinoJM, KeenCL, FragaCG, OteizaPI. Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-kappaB activation at multiple steps in Jurkat T cells. FASEB J, 18:167–169. 2004.
152.
ManachC, ScalbertA, MorandC, RemesyC, JimenezL. Polyphenols: food sources and bioavailability. Am J Clin Nutr, 79:727–747. 2004.
153.
ManachC, WilliamsonG, MorandC, ScalbertA, RemesyC. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr, 81:230S–242S. 2005.
154.
MaoTK, Van de WaterJ, KeenCL, SchmitzHH, GershwinME. Effect of cocoa flavanols and their related oligomers on the secretion of interleukin-5 in peripheral blood mononuclear cells. J Med Food, 5:17–22. 2002.
155.
MarcusDA, ScharffL, TurkD, GourleyLM. A double-blind provocative study of chocolate as a trigger of headache. Cephalalgia, 17:855–862; discussion 8001997.
156.
MartinFP, RezziS, Pere-TrepatE, KamlageB, CollinoS, LeiboldE, KastlerJ, ReinD, FayLB, KochharS. Metabolic effects of dark chocolate consumption on energy, gut microbiota, and stress-related metabolism in free-living subjects. J Proteome Res, 8:5568–5579. 2009.
157.
MaskarinecG. Cancer protective properties of cocoa: a review of the epidemiologic evidence. Nutr Cancer, 61:573–579. 2009.
158.
MassoltET, van HaardPM, RehfeldJF, PosthumaEF, van der VeerE, SchweitzerDH. Appetite suppression through smelling of dark chocolate correlates with changes in ghrelin in young women. Regul Pept, 161:81–86. 2010.
159.
MatsuiN, ItoR, NishimuraE, YoshikawaM, KatoM, KameiM, ShibataH, MatsumotoI, AbeK, HashizumeS. Ingested cocoa can prevent high-fat diet-induced obesity by regulating the expression of genes for fatty acid metabolism. Nutrition, 21:594–601. 2005.
MaytinM, LeopoldJ, LoscalzoJ. Oxidant stress in the vasculature. Curr Atheroscler Rep, 1:156–164. 1999.
162.
McCullochJ, HarperAM. Phenylethylamine and cerebral blood flow. Possible involvement of phenylethylamine in migraine. Neurology, 27:817–821. 1977.
163.
McCullochJ, HarperAM. Factors influencing the response of the cerebral circulation to phenylethylamine. Neurology, 29:201–207. 1979.
164.
McCulloughML, ChevauxK, JacksonL, PrestonM, MartinezG, SchmitzHH, ColettiC, CamposH, HollenbergNK. Hypertension, the Kuna, and the epidemiology of flavanols. J Cardiovasc Pharmacol, 47,Suppl 2:S103–S109; discussion 119–1212006.
165.
McSheaA, LeissleK, SmithMA. The essence of chocolate: a rich, dark, and well-kept secret. Nutrition, 25:1104–1105. 2009.
166.
McSheaA, Ramiro-PuigE, MunroSB, CasadesusG, CastellM, SmithMA. Clinical benefit and preservation of flavonols in dark chocolate manufacturing. Nutr Rev, 66:630–641. 2008.
MellorDD, SathyapalanT, KilpatrickES, BeckettS, AtkinSL. High-cocoa polyphenol-rich chocolate improves HDL cholesterol in type 2 diabetes patients. Diabet Med, 27:1318–1321. 2010.
169.
MichenerW, RozinP. Pharmacological versus sensory factors in the satiation of chocolate craving. Physiol Behav, 56:419–422. 1994.
170.
MillerKB, HurstWJ, FlanniganN, OuB, LeeCY, SmithN, StuartDA. Survey of commercially available chocolate- and cocoa-containing products in the United States. 2. Comparison of flavan-3-ol content with nonfat cocoa solids, total polyphenols, and percent cacao. J Agric Food Chem, 57:9169–9180. 2009.
171.
MillerKB, HurstWJ, PayneMJ, StuartDA, ApgarJ, SweigartDS, OuB. Impact of alkalization on the antioxidant and flavanol content of commercial cocoa powders. J Agric Food Chem, 56:8527–8533. 2008.
172.
MillerKB, StuartDA, SmithNL, LeeCY, McHaleNL, FlanaganJA, OuB, HurstWJ. Antioxidant activity and polyphenol and procyanidin contents of selected commercially available cocoa-containing and chocolate products in the United States. J Agric Food Chem, 54:4062–4068. 2006.
173.
MitchellJA, AliF, BaileyL, MorenoL, HarringtonLS. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium. Exp Physiol, 93:141–147. 2008.
174.
MonagasM, KhanN, Andres-LacuevaC, CasasR, Urpi-SardaM, LlorachR, Lamuela-RaventosRM, EstruchR. Effect of cocoa powder on the modulation of inflammatory biomarkers in patients at high risk of cardiovascular disease. Am J Clin Nutr, 90:1144–1150. 2009.
175.
MoncadaS, HiggsA. The L-arginine-nitric oxide pathway. N Engl J Med, 329:2002–2012. 1993.
MostofskyE, LevitanEB, WolkA, MittlemanMA. Chocolate intake and incidence of heart failure: a population-based, prospective study of middle-aged and elderly women. Circ Heart Fail, 3:612–616. 2010.
178.
MullenW, BorgesG, DonovanJL, EdwardsCA, SerafiniM, LeanME, CrozierA. Milk decreases urinary excretion but not plasma pharmacokinetics of cocoa flavan-3-ol metabolites in humans. Am J Clin Nutr, 89:1784–1791. 2009.
179.
Muller-LissnerSA, KaatzV, BrandtW, KellerJ, LayerP. The perceived effect of various foods and beverages on stool consistency. Eur J Gastroenterol Hepatol, 17:109–112. 2005.
180.
MuniyappaR, HallG, KolodziejTL, KarneRJ, CrandonSK, QuonMJ. Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension. Am J Clin Nutr, 88:1685–1696. 2008.
181.
MurphyDW, CastellDO. Chocolate and heartburn: evidence of increased esophageal acid exposure after chocolate ingestion. Am J Gastroenterol, 83:633–636. 1988.
182.
MurphyKJ, ChronopoulosAK, SinghI, FrancisMA, MoriartyH, PikeMJ, TurnerAH, MannNJ, SinclairAJ. Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr, 77:1466–1473. 2003.
183.
MursuJ, VoutilainenS, NurmiT, RissanenTH, VirtanenJK, KaikkonenJ, NyyssonenK, SalonenJT. Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans. Free Radic Biol Med, 37:1351–1359. 2004.
184.
MyungSK, JuW, ChoiHJ, KimSC. Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis. BJOG, 116:1697–1705. 2009.
185.
NapoliC, IgnarroLJ. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res, 32:1103–1108. 2009.
186.
National Academy of Sciences. Institute of Medicine. Dietary Reference Intakes (DRIs): Recommended Intakes for Individuals, Vitamins. 2004. http://iom.edu/en/Global/News%20Announcements/∼/media/Files/Activity%20Files/Nutrition/DRIs/DRISummaryListing2.ashx. 2010 May 12.
187.
This reference has been deleted.
188.
NeilsonAP, SapperTN, JanleEM, RudolphR, MatusheskiNV, FerruzziMG. Chocolate matrix factors modulate the pharmacokinetic behavior of cocoa flavan-3-ol phase II metabolites following oral consumption by Sprague-Dawley rats. J Agric Food Chem, 58:6685–6691. 2010.
189.
NeukamK, StahlW, TronnierH, SiesH, HeinrichU. Consumption of flavanol-rich cocoa acutely increases microcirculation in human skin. Eur J Nutr, 46:53–56. 2007.
190.
NjikeVY, FaridiZ, ShuvalK, DuttaS, KayCD, WestSG, Kris-EthertonPM, KatzDL. Effects of sugar-sweetened and sugar-free cocoa on endothelial function in overweight adults. Int J Cardiol, 2009[Epub ahead of print];DOI:10.1016/j.ijcard.2009.12.010.
191.
ObaS, NagataC, NakamuraK, FujiiK, KawachiT, TakatsukaN, ShimizuH. Consumption of coffee, green tea, oolong tea, black tea, chocolate snacks and the caffeine content in relation to risk of diabetes in Japanese men and women. Br J Nutr, 103:453–459. 2010.
192.
OlivaresM, UauyR. Copper as an essential nutrient. Am J Clin Nutr, 63:791S–796S. 1996.
193.
OlivieroT, CapuanoE, CammererB, FoglianoV. Influence of roasting on the antioxidant activity and HMF formation of a cocoa bean model systems. J Agric Food Chem, 57:147–152. 2009.
194.
This reference has been deleted.
195.
OsmanJL, SobalJ. Chocolate cravings in American and Spanish individuals: biological and cultural influences. Appetite, 47:290–301. 2006.
196.
OstertagLM, O'KennedyN, KroonPA, DuthieGG, de RoosB. Impact of dietary polyphenols on human platelet function—a critical review of controlled dietary intervention studies. Mol Nutr Food Res, 54:60–81. 2010.
197.
ParkerG, ParkerI, BrotchieH. Mood state effects of chocolate. J Affect Disord, 92:149–159. 2006.
198.
PearsonDA, HoltRR, ReinD, PaglieroniT, SchmitzHH, KeenCL. Flavanols and platelet reactivity. Clin Dev Immunol, 12:1–9. 2005.
199.
PhilipsBJ, CoyleCH, MorrisroeSN, ChancellorMB, YoshimuraN. Induction of apoptosis in human bladder cancer cells by green tea catechins. Biomed Res, 30:207–215. 2009.
200.
PlotnickGD, CorrettiMC, VogelRA. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. JAMA, 278:1682–1686. 1997.
201.
RamiroE, FranchA, CastelloteC, Andres-LacuevaC, Izquierdo-PulidoM, CastellM. Effect of Theobroma cacao flavonoids on immune activation of a lymphoid cell line. Br J Nutr, 93:859–866. 2005.
Ramiro-PuigE, Perez-CanoFJ, Ramirez-SantanaC, CastelloteC, Izquierdo-PulidoM, PermanyerJ, FranchA, CastellM. Spleen lymphocyte function modulated by a cocoa-enriched diet. Clin Exp Immunol, 149:535–42. 2007.
204.
Ramiro-PuigE, Urpi-SardaM, Perez-CanoFJ, FranchA, CastelloteC, Andres-LacuevaC, Izquierdo-PulidoM, CastellM. Cocoa-enriched diet enhances antioxidant enzyme activity and modulates lymphocyte composition in thymus from young rats. J Agric Food Chem, 55:6431–6438. 2007.
205.
RamosS. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem, 18:427–442. 2007.
206.
ReinD, PaglieroniTG, PearsonDA, WunT, SchmitzHH, GosselinR, KeenCL. Cocoa and wine polyphenols modulate platelet activation and function. J Nutr, 130:2120S–2126S. 2000.
207.
ReinD, PaglieroniTG, WunT, PearsonDA, SchmitzHH, GosselinR, KeenCL. Cocoa inhibits platelet activation and function. Am J Clin Nutr, 72:30–35. 2000.
208.
ReunanenA, KnektP, MarniemiJ, MakiJ, MaatelaJ, AromaaA. Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur J Clin Nutr, 50:431–437. 1996.
209.
RiosLY, BennettRN, LazarusSA, RemesyC, ScalbertA, WilliamsonG. Cocoa procyanidins are stable during gastric transit in humans. Am J Clin Nutr, 76:1106–1110. 2002.
210.
RoseN, KoperskiS, GolombBA. Mood food: chocolate and depressive symptoms in a cross-sectional analysis. Arch Intern Med, 170:699–703. 2010.
211.
RossR. Atherosclerosis—an inflammatory disease. N Engl J Med, 340:115–126. 1999.
212.
RouraE, Andres-LacuevaC, EstruchR, Lourdes Mata BilbaoM, Izquierdo-PulidoM, Lamuela-RaventosRM. The effects of milk as a food matrix for polyphenols on the excretion profile of cocoa (-)-epicatechin metabolites in healthy human subjects. Br J Nutr, 100:846–851. 2008.
213.
RouraE, Andres-LacuevaC, EstruchR, Mata-BilbaoML, Izquierdo-PulidoM, WaterhouseAL, Lamuela-RaventosRM. Milk does not affect the bioavailability of cocoa powder flavonoid in healthy human. Ann Nutr Metab, 51:493–498. 2007.
214.
RozinP, LevineE, StoessC. Chocolate craving and liking. Appetite, 17:199–212. 1991.
215.
RuzaidiA, AminI, NawalyahAG, HamidM, FaizulHA. The effect of Malaysian cocoa extract on glucose levels and lipid profiles in diabetic rats. J Ethnopharmacol, 98:55–60. 2005.
216.
SaariJT. Copper deficiency and cardiovascular disease: role of peroxidation, glycation, and nitration. Can J Physiol Pharmacol, 78:848–855. 2000.
217.
SchachingerV, BrittenMB, ZeiherAM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation, 101:1899–1906. 2000.
218.
ScheweT, SteffenY, SiesH. How do dietary flavanols improve vascular function? A position paper. Arch Biochem Biophys, 476:102–106. 2008.
219.
SchmittCA, DirschVM. Modulation of endothelial nitric oxide by plant-derived products. Nitric Oxide, 21:77–91. 2009.
220.
ScholeyAB, FrenchSJ, MorrisPJ, KennedyDO, MilneAL, HaskellCF. Consumption of cocoa flavanols results in acute improvements in mood and cognitive performance during sustained mental effort. J Psychopharmacol, 24:1505–1514. 2010.
221.
SchrammDD, KarimM, SchraderHR, HoltRR, KirkpatrickNJ, PolagrutoJA, EnsunsaJL, SchmitzHH, KeenCL. Food effects on the absorption and pharmacokinetics of cocoa flavanols. Life Sci, 73:857–869. 2003.
222.
SchrammDD, WangJF, HoltRR, EnsunsaJL, GonsalvesJL, LazarusSA, SchmitzHH, GermanJB, KeenCL. Chocolate procyanidins decrease the leukotriene-prostacyclin ratio in humans and human aortic endothelial cells. Am J Clin Nutr, 73:36–40. 2001.
223.
SchroeterH, BahiaP, SpencerJP, SheppardO, RattrayM, CadenasE, Rice-EvansC, WilliamsRJ. (-)Epicatechin stimulates ERK-dependent cyclic AMP response element activity and up-regulates GluR2 in cortical neurons. J Neurochem, 101:1596–1606. 2007.
224.
SchroeterH, HeissC, BalzerJ, KleinbongardP, KeenCL, HollenbergNK, SiesH, Kwik-UribeC, SchmitzHH, KelmM. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A, 103:1024–1029. 2006.
225.
SchwabUS, MalirantaHM, SarkkinenES, SavolainenMJ, KesaniemiYA, UusitupaMI. Different effects of palmitic and stearic acid-enriched diets on serum lipids and lipoproteins and plasma cholesteryl ester transfer protein activity in healthy young women. Metabolism, 45:143–149. 1996.
226.
SeligsonFH, KrummelDA, ApgarJL. Patterns of chocolate consumption. Am J Clin Nutr, 60:1060S–1064S. 1994.
227.
SelmiC, CocchiCA, LanfrediniM, KeenCL, GershwinME. Chocolate at heart: the anti-inflammatory impact of cocoa flavanols. Mol Nutr Food Res, 52:1340–1348. 2008.
228.
SelmiC, MaoTK, KeenCL, SchmitzHH, Eric GershwinM. The anti-inflammatory properties of cocoa flavanols. J Cardiovasc Pharmacol, 47,Suppl 2:S163–S171; discussion S172–S1762006.
229.
SerafiniM, BugianesiR, MaianiG, ValtuenaS, De SantisS, CrozierA. Plasma antioxidants from chocolate. Nature, 424:1013. 2003.
230.
SessaWC. eNOS at a glance. J Cell Sci, 117:2427–2429. 2004.
231.
ShapiroH, LevS, CohenJ, SingerP. Polyphenols in the prevention and treatment of sepsis syndromes: rationale and pre-clinical evidence. Nutrition, 25:981–997. 2009.
232.
SharmaSD, MeeranSM, KatiyarSK. Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors. Mol Cancer Ther, 9:569–580. 2010.
233.
ShiinaY, FunabashiN, LeeK, MurayamaT, NakamuraK, WakatsukiY, DaimonM, KomuroI. Acute effect of oral flavonoid-rich dark chocolate intake on coronary circulation, as compared with non-flavonoid white chocolate, by transthoracic Doppler echocardiography in healthy adults. Int J Cardiol, 131:424–429. 2009.
234.
ShivelyCA, TarkaSM.Jr. Methylxanthine composition and consumption patterns of cocoa and chocolate products. Prog Clin Biol Res, 158:149–178. 1984.
235.
SiesH, ScheweT, HeissC, KelmM. Cocoa polyphenols and inflammatory mediators. Am J Clin Nutr, 81:304S–312S. 2005.
236.
SinghM, ArseneaultM, SandersonT, MurthyV, RamassamyC. Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms. J Agric Food Chem, 56:4855–4873. 2008.
237.
SmitHJ, BlackburnRJ. Reinforcing effects of caffeine and theobromine as found in chocolate. Psychopharmacology (Berl), 181:101–106. 2005.
238.
SmitHJ, GaffanEA, RogersPJ. Methylxanthines are the psycho-pharmacologically active constituents of chocolate. Psychopharmacology (Berl), 176:412–419. 2004.
239.
SongY, MansonJE, CookNR, AlbertCM, BuringJE, LiuS. Dietary magnesium intake and risk of cardiovascular disease among women. Am J Cardiol, 96:1135–1141. 2005.
240.
SorondFA, LipsitzLA, HollenbergNK, FisherND. Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans. Neuropsychiatr Dis Treat, 4:433–440. 2008.
241.
SpadafrancaA, Martinez ConesaC, SiriniS, TestolinG. Effect of dark chocolate on plasma epicatechin levels, DNA resistance to oxidative stress and total antioxidant activity in healthy subjects. Br J Nutr, 103:1008–1014. 2010.
242.
SpencerJP. The interactions of flavonoids within neuronal signalling pathways. Genes Nutr, 2:257–273. 2007.
SpencerJP. Flavonoids and brain health: multiple effects underpinned by common mechanisms. Genes Nutr, 4:243–250. 2009.
245.
SpencerJP, Abd-el-MohsenMM, Rice-EvansC. Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity. Arch Biochem Biophys, 423:148–161. 2004.
246.
StahlL, MillerKB, ApgarJ, SweigartDS, StuartDA, McHaleN, OuB, KondoM, HurstWJ. Preservation of cocoa antioxidant activity, total polyphenols, flavan-3-ols, and procyanidin content in foods prepared with cocoa powder. J Food Sci, 74:C456–C461. 2009.
247.
SteffenY, JungT, KlotzLO, ScheweT, GruneT, SiesH. Protein modification elicited by oxidized low-density lipoprotein (LDL) in endothelial cells: protection by (-)-epicatechin. Free Radic Biol Med, 42:955–970. 2007.
248.
SteffenY, ScheweT, SiesH. Myeloperoxidase-mediated LDL oxidation and endothelial cell toxicity of oxidized LDL: attenuation by (-)-epicatechin. Free Radic Res, 40:1076–1085. 2006.
249.
SteffenY, ScheweT, SiesH. (-)-Epicatechin elevates nitric oxide in endothelial cells via inhibition of NADPH oxidase. Biochem Biophys Res Commun, 359:828–833. 2007.
250.
SteinbergFM, BeardenMM, KeenCL. Cocoa and chocolate flavonoids: implications for cardiovascular health. J Am Diet Assoc, 103:215–223. 2003.
251.
StipanukM. Biochemical and Physiological Aspects of Human Nutrition. Philadelphia: Saunders Company, 2000.
252.
StocletJC, ChataigneauT, NdiayeM, OakMH, El BedouiJ, ChataigneauM, Schini-KerthVB. Vascular protection by dietary polyphenols. Eur J Pharmacol, 500:299–313. 2004.
253.
StrandbergTE, StrandbergAY, PitkalaK, SalomaaVV, TilvisRS, MiettinenTA. Chocolate, well-being and health among elderly men. Eur J Clin Nutr, 62:247–253. 2008.
254.
SuganumaM, OkabeS, KaiY, SueokaN, SueokaE, FujikiH. Synergistic effects of (—)-epigallocatechin gallate with (—)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res, 59:44–47. 1999.
255.
SuwaidiJA, HamasakiS, HiganoST, NishimuraRA, HolmesDR.Jr., LermanA. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation, 101:948–954. 2000.
256.
SydowK, MondonCE, CookeJP. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. Vasc Med, 10,Suppl 1:S35–S43. 2005.
257.
TaubertD, BerkelsR, RoesenR, KlausW. Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA, 290:1029–1030. 2003.
258.
TaubertD, RoesenR, LehmannC, JungN, SchomigE. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA, 298:49–60. 2007.
U.S. Food and Drug Administration. 2010. CFR—Code of Federal Regulations Title 21. www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=163&showFR=1. 2010 September 20.
261.
UauyR, OlivaresM, GonzalezM. Essentiality of copper in humans. Am J Clin Nutr, 67:952S–959S. 1998.
262.
UeshimaK. Magnesium and ischemic heart disease: a review of epidemiological, experimental, and clinical evidences. Magnes Res, 18:275–284. 2005.
263.
UmesawaM, IsoH, DateC, YamamotoA, ToyoshimaH, WatanabeY, KikuchiS, KoizumiA, KondoT, InabaY, TanabeN, TamakoshiA. Relations between dietary sodium and potassium intakes and mortality from cardiovascular disease: the Japan Collaborative Cohort Study for Evaluation of Cancer Risks. Am J Clin Nutr, 88:195–202. 2008.
264.
United States Department of Agriculture. Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans. 2010.
265.
Urpi-SardaM, LlorachR, KhanN, MonagasM, Rotches-RibaltaM, Lamuela-RaventosR, EstruchR, TinahonesFJ, Andres-LacuevaC. Effect of milk on the urinary excretion of microbial phenolic acids after cocoa powder consumption in humans. J Agric Food Chem, 58:4706–4711. 2010.
266.
Urpi-SardaM, Ramiro-PuigE, KhanN, Ramos-RomeroS, LlorachR, CastellM, Gonzalez-ManzanoS, Santos-BuelgaC, Andres-LacuevaC. Distribution of epicatechin metabolites in lymphoid tissues and testes of young rats with a cocoa-enriched diet. Br J Nutr, 103:1393–1397. 2010.
267.
USDA National Nutrient Database for Standard ReferenceRelease 222009.
VogelRA. Measurement of endothelial function by brachial artery flow-mediated vasodilation. Am J Cardiol, 88:31E–34E. 2001.
270.
WanY, VinsonJA, EthertonTD, ProchJ, LazarusSA, Kris-EthertonPM. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am J Clin Nutr, 74:596–602. 2001.
271.
WangJF, SchrammDD, HoltRR, EnsunsaJL, FragaCG, SchmitzHH, KeenCL. A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J Nutr, 130:2115S–2119S. 2000.
272.
Wang-PolagrutoJF, VillablancaAC, PolagrutoJA, LeeL, HoltRR, SchraderHR, EnsunsaJL, SteinbergFM, SchmitzHH, KeenCL. Chronic consumption of flavanol-rich cocoa improves endothelial function and decreases vascular cell adhesion molecule in hypercholesterolemic postmenopausal women. J Cardiovasc Pharmacol, 47,Suppl 2:S177–S186; discussion S206–S2092006.
273.
WeickertMO, PfeifferAF. Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr, 138:439–442. 2008.
274.
WeisburgerJH. Antimutagenesis and anticarcinogenesis, from the past to the future. Mutat Res, 480–481:23–35. 2001.
275.
WeisburgerJH. Chemopreventive effects of cocoa polyphenols on chronic diseases. Exp Biol Med (Maywood), 226:891–897. 2001.
276.
WelschCA, LachancePA, WassermanBP. Dietary phenolic compounds: inhibition of Na+-dependent D-glucose uptake in rat intestinal brush border membrane vesicles. J Nutr, 119:1698–1704. 1989.
277.
WidlanskyME, GokceN, KeaneyJF.Jr., VitaJA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol, 42:1149–1160. 2003.
278.
WilliamsMJ, SutherlandWH, McCormickMP, de JongSA, WalkerRJ, WilkinsGT. Impaired endothelial function following a meal rich in used cooking fat. J Am Coll Cardiol, 33:1050–1055. 1999.
279.
WilliamsS, TamburicS, LallyC. Eating chocolate can significantly protect the skin from UV light. J Cosmet Dermatol, 8:169–173. 2009.
280.
WilliamsonG. Bioavailability and health effects of cocoa polyphenols. Inflammopharmacology, 17:111. 2009.
281.
WillnerP, BentonD, BrownE, CheetaS, DaviesG, MorganJ, MorganM. “Depression” increases “craving” for sweet rewards in animal and human models of depression and craving. Psychopharmacology (Berl), 136:272–283. 1998.
282.
WoberC, HolzhammerJ, ZeitlhoferJ, WesselyP, Wober-BingolC. Trigger factors of migraine and tension-type headache: experience and knowledge of the patients. J Headache Pain, 7:188–195. 2006.
283.
WoodsideJV, McKinleyMC, YoungIS. Saturated and trans fatty acids and coronary heart disease. Curr Atheroscler Rep, 10:460–466. 2008.
284.
World Cocoa Foundation. How chocolate is made. www.worldcocoafoundation.org/learn-about-cocoa/tree-to-table/how-chocolate-is-made.asp. 2010 January 10.
285.
WrightLE, CastellDO. The adverse effect of chocolate on lower esophageal sphincter pressure. Am J Dig Dis, 20:703–707. 1975.
286.
YangCS, WangX, LuG, PicinichSC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer, 9:429–439. 2009.
287.
YeboahJ, CrouseJR, HsuFC, BurkeGL, HerringtonDM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation, 115:2390–2397. 2007.
288.
YeboahJ, FolsomAR, BurkeGL, JohnsonC, PolakJF, PostW, LimaJA, CrouseJR, HerringtonDM. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation, 120:502–509. 2009.
289.
YusufS, HawkenS, OunpuuS, DansT, AvezumA, LanasF, McQueenM, BudajA, PaisP, VarigosJ, LishengL, InvestigatorsIS. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet, 364:937–952. 2004.
290.
ZadakZ, HysplerR, TichaA, HronekM, FikrovaP, RathouskaJ, HrnciarikovaD, StetinaR. Antioxidants and vitamins in clinical conditions. Physiol Res, 58,Suppl 1:S13–S17. 2009.
291.
ZellnerDA, Garriga-TrilloA, CentenoS, WadsworthE. Chocolate craving and the menstrual cycle. Appetite, 42:119–21. 2004.
292.
ZellnerDA, Garriga-TrilloA, RohmE, CentenoS, ParkerS. Food liking and craving: A cross-cultural approach. Appetite, 33:61–70. 1999.
